# Case Report: Severe vitamin D deficiency in a girl with inflammatory myopathy and myonecrosis

**Authors:** Andrew Kanouse, Benjamin Udoka Nwosu, Parissa Salemi

PMC · DOI: 10.3389/fped.2024.1339875 · 2024-02-12

## TL;DR

A girl with severe muscle disease improved significantly after being treated for vitamin D deficiency, suggesting a link between the deficiency and her condition.

## Contribution

This case report highlights a potential association between vitamin D deficiency and myonecrosis, suggesting routine vitamin D testing for such patients.

## Key findings

- The patient showed significant clinical improvement after calcium and vitamin D supplementation.
- Vitamin D deficiency was identified as a treatable factor in a case of myonecrosis.
- The case suggests hypocalcemia and vitamin D deficiency may coexist with myonecrosis.

## Abstract

Inflammatory myopathies are a rare group of disorders that can cause significant disruption in the ability of an individual to adequately perform activities of daily living. In this case report, we present a case of a girl presenting with a substantial compromise of her ambulation with a muscle biopsy consistent with myonecrosis. She was subsequently diagnosed with an inflammatory myopathy and started on glucocorticoid and methotrexate therapy with minimal symptomatic improvement. Further in her clinical course, hypocalcemia and an undetectable 25-hydroxyvitamin D level were detected. Prompt institution of calcium and vitamin D supplementation significantly improved her myopathic condition. While there is evidence in the literature linking vitamin D deficiency with myopathy, there is a lack of data on the association between hypocalcemia and vitamin D deficiency with myonecrosis, which could represent comorbid states in myonecrosis. Therefore, vitamin D status should be established in all patients with myonecrosis, as vitamin D deficiency is easy to diagnose and treat, as exemplified in our patient’s case, which shows that such treatment could lead to significant clinical improvement.

## Linked entities

- **Chemicals:** 25-hydroxyvitamin D (PubChem CID 5353325), calcium (PubChem CID 5460341), methotrexate (PubChem CID 4112)
- **Diseases:** inflammatory myopathy (MONDO:0007827), myonecrosis (MONDO:0005767)

## Full-text entities

- **Diseases:** vitamin D deficiency (MESH:D014808), hypocalcemia (MESH:D006996), myopathic (MESH:D009135), Inflammatory myopathies (MESH:D009220)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC10894911/full.md

---
Source: https://tomesphere.com/paper/PMC10894911